hydralazine has been researched along with Blood Coagulation Disorders in 3 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Blood Coagulation Disorders: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HC | 1 |
| Hsiao, TS | 1 |
| Liao, MH | 1 |
| Tsao, CM | 1 |
| Shih, CC | 1 |
| Wu, CC | 1 |
| Vaziri, ND | 1 |
| Leroux-Robert, C | 1 |
| Beaufils, M | 1 |
| Richet, G | 1 |
1 review available for hydralazine and Blood Coagulation Disorders
| Article | Year |
|---|---|
Malignant or accelerated hypertension.
Topics: Blood Coagulation Disorders; Brain Diseases; Diazoxide; Glomerulosclerosis, Focal Segmental; Humans; | 1984 |
2 other studies available for hydralazine and Blood Coagulation Disorders
| Article | Year |
|---|---|
Low-dose hydralazine improves endotoxin-induced coagulopathy and multiple organ dysfunction via its anti-inflammatory and anti-oxidative/nitrosative properties.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta, Thoracic; Blood Coagulation Disorders; Blood | 2020 |
[Pregnancy toxemia. Mechanism, prevention and treatment].
Topics: Blood Coagulation Disorders; Diet, Sodium-Restricted; Diuretics; Eclampsia; Edema; Female; Hospitali | 1974 |